Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and NeckGlenn J. Hanna, Robert I. Haddad, Patrick H. Lizotte et al.|Clinical Cancer Research|2021Cited by 104
Nivolumab for Patients With High-Risk Oral LeukoplakiaGlenn J. Hanna, Sook‐Bin Woo, Alessandro Villa et al.|JAMA Oncology|2023Cited by 56
Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized LeukoplakiaGlenn J. Hanna, F. Stephen Hodi, Alessandro Villa et al.|Cancer Research Communications|2021Cited by 28
Hemoglobin Southampton complicated by cerebral ischemia, moyamoya, and hydroxyurea‐induced methemoglobinemiaAlexander A. Boucher, Charles T. Quinn, Arun Gurunathan et al.|American Journal of Hematology|2019Cited by 5